País: Estats Units
Idioma: anglès
Font: NLM (National Library of Medicine)
Promethazine Hydrochloride (UNII: R61ZEH7I1I) (Promethazine - UNII:FF28EJQ494)
Henry Schein, Inc.
INTRAMUSCULAR
PRESCRIPTION DRUG
Promethazine hydrochloride injection is indicated for the following conditions: - Amelioration of allergic reactions to blood or plasma. - In anaphylaxis as an adjunct to epinephrine and other standard measures after the acute symptoms have been controlled. - For other uncomplicated allergic conditions of the immediate type when oral therapy is impossible or contraindicated. - For sedation and relief of apprehension and to produce light sleep from which the patient can be easily aroused. - Active treatment of motion sickness. - Prevention and control of nausea and vomiting associated with certain types of anesthesia and surgery. - As an adjunct to analgesics for the control of postoperative pain. - Preoperative, postoperative, and obstetric (during labor) sedation. - Intravenously in special surgical situations, such as repeated bronchoscopy, ophthalmic surgery, and poor-risk patients, with reduced amounts of meperidine or other narcotic analgesic as an adjunct to anesthesia and analgesia. Children Less Than
Promethazine Hydrochloride Injection, USP is available as follows: Storage Store at 20°-25°C (68°-77°F) [see USP Controlled Room Temperature]. Protect from light. Keep covered in carton until time of use. Do not use if solution has developed color or contains a precipitate. To report SUSPECTED ADVERSE REACTIONS, contact West-Ward Pharmaceutical Corp. at 1-877-845-0689, or the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. For Product Inquiry call 1-877-845-0689 Manufactured by: HIKMA FARMACEUTICA (PORTUGAL), S.A. Estrada do Rio da Mo, 8, 8A e 8B - Fervenca - 2705-906 Terrugem SNT, PORTUGAL Distributed by: Hikma Pharmaceuticals USA Inc. Berkley Heights, NJ 07922 Revised September 2020 462-638-02 PIN292-WES/3
Abbreviated New Drug Application
PROMETHAZINE HYDROCHLORIDE - PROMETHAZINE HYDROCHLORIDE INJECTION HENRY SCHEIN, INC. ---------- PROMETHAZINE HCL 25 MG/ML INJECTION, USP 1 ML SINGLE DOSE AMPULE BOXED WARNING WARNINGS RESPIRATORY DEPRESSION – PEDIATRICS PROMETHAZINE HYDROCHLORIDE INJECTION SHOULD NOT BE USED IN PEDIATRIC PATIENTS LESS THAN 2 YEARS OF AGE BECAUSE OF THE POTENTIAL FOR FATAL RESPIRATORY DEPRESSION. POSTMARKETING CASES OF RESPIRATORY DEPRESSION, INCLUDING FATALITIES, HAVE BEEN REPORTED WITH USE OF PROMETHAZINE IN PEDIATRIC PATIENTS LESS THAN 2 YEARS OF AGE. CAUTION SHOULD BE EXERCISED WHEN ADMINISTERING PROMETHAZINE HYDROCHLORIDE INJECTION TO PEDIATRIC PATIENTS 2 YEARS OF AGE AND OLDER (SEE WARNINGS - RESPIRATORY DEPRESSION). SEVERE TISSUE INJURY, INCLUDING GANGRENEPROMETHAZINE HYDROCHLORIDE INJECTION CAN CAUSE SEVERE CHEMICAL IRRITATION AND DAMAGE TO TISSUES REGARDLESS OF THE ROUTE OF ADMINISTRATION. IRRITATION AND DAMAGE CAN RESULT FROM PERIVASCULAR EXTRAVASATION, UNINTENTIONAL INTRA-ARTERIAL INJECTION, AND INTRANEURONAL OR PERINEURONAL INFILTRATION. ADVERSE REACTIONS INCLUDE BURNING, PAIN, THROMBOPHLEBITIS, TISSUE NECROSIS, AND GANGRENE. IN SOME CASES, SURGICAL INTERVENTION, INCLUDING FASCIOTOMY, SKIN GRAFT, AND/OR AMPUTATION HAVE BEEN REQUIRED (SEE WARNINGS - SEVERE TISSUE INJURY, INCLUDING GANGRENE). DUE TO THE RISKS OF INTRAVENOUS INJECTION, THE PREFERRED ROUTE OF ADMINISTRATION OF PROMETHAZINE HYDROCHLORIDE INJECTION IS DEEP INTRAMUSCULAR INJECTION. SUBCUTANEOUS INJECTION IS CONTRAINDICATED. SEE DOSAGE AND ADMINISTRATION FOR IMPORTANT NOTES ON ADMINISTRATION. DESCRIPTION Promethazine hydrochloride injection, USP is a sterile, pyrogen-free solution for deep intramuscular or intravenous administration. Promethazine hydrochloride (10H- Phenothiazine-10-ethanamine,N,N,a-trimethyl-, monohydrochloride, (±)-) is a racemic compound and has the following structural formula: Each mL contains promethazine hydrochloride, either 25 mg or 50 mg, edetate disodium 0.1 mg, calcium chloride 0.04 mg, sodium metabisulfite 0.25 mg and phenol 5 Llegiu el document complet